Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis
{{output}}
Aim: This study evaluated the influence of pharmacogenetics in psoriatic patients treated with adalimumab and/or infliximab. Materials & methods: ... ...
